Masimo Corporation
Masimo to be Acquired by Danaher for $180.00 Per Share
Summary
On February 16, 2026, Masimo Corporation announced a definitive agreement to be acquired by Danaher Corporation for $180.00 per share in cash, totaling $9.9 billion. The acquisition, unanimously approved by both companies' boards, will see Masimo become a standalone business unit within Danaher's Diagnostics segment. The transaction is expected to close in the second half of 2026, subject to regulatory approvals and other customary closing conditions. Masimo will also pay Danaher a termination fee of $305 million under certain circumstances, such as terminating the agreement to accept a superior proposal.
Profitelligence Alerts
Get alerts for MASI
Be first to know when Masimo Corporation files with the SEC.
Filing Categories
Advertisement
About Masimo Corporation
Masimo Corporation is a global leader in noninvasive monitoring technologies, specifically focusing on developing innovative medical devices that improve patient outcomes and reduce the cost of care. The company's flagship product line includes advanced signal processing pulse oximetry devices, which are pivotal in accurately measuring oxygen levels, pulse rate, and other vital signals without the need for invasive procedures. Masimo's technology is widely adopted across various healthcare settings including hospitals, outpatient treatment centers, and alternative care sites, enhancing patient monitoring and aiding clinicians in detecting potential health issues more efficiently. Besides, Masimo’s products are recognized for their precision and reliability, demonstrating robustness even in challenging clinical environments where motion and low perfusion can affect monitoring accuracy. The corporation is committed to expanding its technological suite, covering a spectrum of health monitoring solutions that contribute to improved healthcare practices globally. Based in Irvine, California, Masimo's ongoing innovation continues to set benchmarks in the healthcare industry, influencing a wide range of sectors from emergency care to surgical and critical care monitoring.
Official SEC Documents
Advertisement